Clik here to view.
森永乳业：超重成人补充益生菌可减少脂肪
东京 (美国商业资讯)–日本第二大乳品公司森永乳业株式会社（东京证券交易所：2264）证实，一项随机、双盲、平行对照试验显示，在有肥胖趋势的成人中，公司的新益生菌成份短双歧杆菌B-3可显著减少体脂，并改善代谢功能。...
View ArticleClik here to view.
Morinaga Milk Industry: Probiotic Supplementation Causes Fat Loss in...
TOKYO Morinaga Milk Industry Co., Ltd. (TOKYO:2264), the second largest dairy product company in Japan, confirmed that its new probiotic ingredient, Bifidobacterium breve B-3, caused a significant...
View ArticleClik here to view.
Japanese Biotech JCR Pharmaceuticals Selects Medidata’s Cloud-Based Platform...
NEW YORK Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its cloud-based technology platform has been...
View ArticleClik here to view.
エリテックが2件の肯定的なDSMB評価結果を発表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック・ファーマ（Paris:ERYP）（ADR:EYRYY）（Euronext Paris – ERYP; OTC US –...
View ArticleClik here to view.
Biogen and Sobi Announce European Medicines Agency Validates ALPROLIX®...
CAMBRIDGE, Mass. & STOCKHOLM Biogen (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) today announced that the European Medicines Agency (EMA) has accepted the Marketing...
View ArticleClik here to view.
ユニバーセル・バイオソリューションズが産業的／標準的手法をとるhiPS細胞株生産のセンターオブエクスパティーズを開設
仏トゥールーズ （ビジネスワイヤ） — 創薬用のヒト誘導多能性幹細胞（hiPSC）およびhiPS由来細胞製品を供給する一流企業のユニバーセル・バイオソリューションズは本日、産業的／標準的手法をとるhiPSC生産のセンターオブエクスパティーズの開設を発表します。...
View ArticleClik here to view.
REVOLVE™ Fat Grafting System by Acelity Now Available in Europe
SAN ANTONIO Acelity, a global wound care and regenerative medicine company, announced today that its patented REVOLVE™ System is now available in Europe. REVOLVE™ System offers fast, efficient and...
View ArticleClik here to view.
Colorcon Continues Investment in China – Helping Accelerate Pharmaceutical...
HARLEYSVILLE, Pa. Colorcon officially opened a new technical service laboratory in Beijing, China on June 25, 2015. Located in the Beijing YiZhuang Biomedical Park, this technical centre is in a...
View ArticleClik here to view.
Gynesonics’ Sonata™ System Winner of 2015 Medical Design Excellence Award
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that its Sonata System was...
View ArticleClik here to view.
Stemgent, a ReproCELL Group Company Launches a New High Performance...
YOKOHAMA, Japan We are pleased to announce that Stemgent Inc. (Cambridge, MA), a ReproCELL Group Company (Yokohama, Japan – JASDAQ: 4978) has launched its new Stemgent StemRNA™-SR Reprogramming Kit,...
View ArticleClik here to view.
SpineGuard Obtains Regulatory Clearance to Sell PediGuard® in the World’s...
PARIS & SAN FRANCISCO SpineGuard (FR0011464452 – ALSGD) announced today that it has received regulatory clearance to market its Classic PediGuard® products in China. “This regulatory clearance...
View ArticleClik here to view.
Prana Announces Safety Outcomes of Alzheimer’s IMAGINE Extension Trial
MELBOURNE, Australia Prana Biotechnology (ASX:PBT) (NASDAQ:PRAN) has today announced the safety outcomes of the IMAGINE Extension study in patients with Alzheimer’s disease. A 250mg dose of PBT2 was...
View ArticleClik here to view.
土耳其顶尖大学医院采用Masimo SpHb用于血红蛋白的连续无创监测
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，土耳其Malatya 的Turgut Ozal医疗中心肝病医院已安装了Masimo的无创连续血红蛋白(SpHb®)技术，用于监测手术患者。...
View ArticleClik here to view.
トルコの一流大学病院が非侵襲的・連続的ヘモグロビン測定でマシモのSpHb技術を導入
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、トルコ・マラティヤのトゥルグト・オザル医療センター肝臓病院が外科患者をモニタリングするためにマシモの非侵襲的・連続的ヘモグロビン（SpHb®）測定技術を導入したと発表しました。...
View ArticleClik here to view.
Overcoming Challenges in Sequence Analysis of FFPE Tissue Due to...
BOLOGNA, Italy Silicon Biosystems, a Bologna (Italy) and San Diego (CA, USA) based biotech company that is part of the pharmaceutical Menarini Group, presented recent findings obtained with its...
View ArticleClik here to view.
GlySure Secures CE Mark and Launches World’s First Continuous Intravascular...
ABINGDON, England GlySure Limited today announced that it has secured the CE Mark for the world’s first and only Continuous Intravascular Glucose Monitoring System (CIGMS). The initial use of the...
View ArticleClik here to view.
NuGEN Scientists Screen 400+ Genes for Fusion Events in Single Assay; Detect...
SAN CARLOS, Calif. Scientists at NuGEN Technologies, Inc. have simultaneously surveyed RNA of more than 400 targeted genes in a single assay, using next generation sequencing (NGS) to detect fusions...
View ArticleClik here to view.
Provectus Biopharmaceuticals Signs Letter of Intent with Boehringer Ingelheim...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, http://www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”),...
View ArticleClik here to view.
Quintiles and Quest Diagnostics Launch Q2 Solutions
RESEARCH TRIANGLE PARK, N.C. & MADISON, N.J. Quintiles and Quest Diagnostics today announced the launch of Q2 Solutions, their new combined clinical trials laboratory services organization. Q2...
View ArticleClik here to view.
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Harvoni®,...
FOSTER CITY, Calif. Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg),...
View Article